High osteoprotegerin levels predict MACCE in STEMI patients, but are not associated with myocardial salvage

Keyphrases

• Acute ST-elevation Myocardial Infarction 9%
• Adverse Cardiac Events 100%
• Assessment Data 9%
• Body Mass Index 9%
• Cardiovascular Diagnosis 9%
• Cardiovascular Disease 9%
• Cerebrovascular Accident 100%
• Circulating Levels 9%
• Consecutive Patients 9%
• CT Examination 9%
• Final Infarct Size 18%
• Heart Failure 9%
• Immunoassay 9%
• Ischemic Stroke 9%
• Myocardial Area at Risk 9%
• Myocardial Infarction 9%
• Myocardial Injury 18%
• Myocardial Salvage 100%
• Non-associated 100%
• Osteoprotegerin 100%
• Predictive Power 9%
• Primary Percutaneous Coronary Intervention 18%
• Prognostic Impact 9%
• Remote Ischemic Preconditioning 18%
• Single-photon Emission Computed Tomography (SPECT) 9%
• STEMI Patients 100%
• Stroke Readmissions 9%
• Transient Ischemic Attack 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Ischemia 9%
• Cardiovascular Disease 9%
• Heart Failure 9%
• Heart Infarction 9%
• Heart Muscle Injury 18%
• Immunoassay 9%
• Infarction 18%
• Osteoprotegerin 100%
• ST Segment Elevation Myocardial Infarction 9%
• Transient Ischemic Attack 9%